Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Immunoglobulin epsilon Fc receptor antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Leukemia 1 D007938 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 357613-86-6
ChEMBL CHEMBL2109151
FDA SRS 8Z13S29R5A